UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Journal of clinical oncology, 2017-11, Vol.35 (32), p.3638-3646

2017

Volltextzugriff (PDF)

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

JNCI : Journal of the National Cancer Institute, 2010-05, Vol.102 (10), p.680-691

2010

Volltextzugriff (PDF)

Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing

Modern pathology, 2019-12, Vol.32 (12), p.1823-1833

2019

Volltextzugriff (PDF)

Evaluation of a comprehensive geriatric assessment tool in geriatric cancer patients undergoing adjuvant chemotherapy: a pilot study

Supportive care in cancer, 2019-05, Vol.27 (5), p.1871-1877

2019

Volltextzugriff (PDF)

Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?

Breast cancer research and treatment, 2008-04, Vol.108 (3), p.307-317

2008

Volltextzugriff (PDF)

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Cancer, 2010-01, Vol.116 (2), p.284-291

2010

Volltextzugriff (PDF)

Approach to inflammatory breast cancer

Canadian family physician, 2009-01, Vol.55 (1), p.25-31

2009

Volltextzugriff (PDF)

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Annals of allergy, asthma, & immunology, 2021-09, Vol.127 (3), p.378-379

2021

Volltextzugriff (PDF)

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-07-01-OT1-07-01

2022

Volltextzugriff (PDF)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-01-01-OT1-01-01

2022

Volltextzugriff (PDF)

Underestimation of risk by Gail model extends beyond women with atypical hyperplasia

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1526; author reply 1527-1526

2009

Volltextzugriff (PDF)

Chemotherapy Dose-dense treatment for triple-negative breast cancer

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.79-80

2010

Volltextzugriff (PDF)

Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD8-01-PD8-01

2022

Volltextzugriff (PDF)

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Current oncology (Toronto), 2024-08, Vol.31 (8), p.4531-4545

2024

Volltextzugriff (PDF)

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients

Supportive care in cancer, 2017-06, Vol.25 (6), p.1881-1886

2017

Volltextzugriff (PDF)

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D 3 in breast cancer patients with bone metastases

Cancer, 2010-01, Vol.116 (2), p.284-291

2010

Volltextzugriff (PDF)

Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.295-307

2014

Volltextzugriff (PDF)

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials

Supportive care in cancer, 2011-03, Vol.19 (3), p.315-322

2011

Volltextzugriff (PDF)

Amenorrhoea, menopause, and endocrine therapy for breast cancer

BMJ. British medical journal (International ed.), 2010-01, Vol.340 (7736), p.48

International edition, 2010

Volltextzugriff (PDF)

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1919; author reply 1920-1919

2009

Volltextzugriff (PDF)

Dose-dense treatment for triple-negative breast cancer

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.79-80

2010

Volltextzugriff (PDF)

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Breast cancer research and treatment, 2009-11, Vol.118 (2), p.377-383

2009

Volltextzugriff (PDF)

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases

Cancer, 2010-01, Vol.116 (2), p.284

2010

Volltextzugriff (PDF)

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.377

2009

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(30)

Sprache

Englisch
(37)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Female
(18)
Oncology
(13)
Breast Cancer
(12)
Breast Neoplasms - Drug Therapy
(10)
Aged
(9)
Adult
(8)
Middle Aged
(8)
Chemotherapy
(7)
Aged, 80 And Over
(6)
Biological And Medical Sciences
(6)
Cancer
(6)
Medical Sciences
(6)
Tumors
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Care And Treatment
(5)
Medicine
(5)
Medicine & Public Health
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing

Evaluation of a comprehensive geriatric assessment tool in geriatric cancer patients undergoing adjuvant chemotherapy: a pilot study

Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Approach to inflammatory breast cancer

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Underestimation of risk by Gail model extends beyond women with atypical hyperplasia

Chemotherapy Dose-dense treatment for triple-negative breast cancer

Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D 3 in breast cancer patients with bone metastases

Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials

Amenorrhoea, menopause, and endocrine therapy for breast cancer

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Dose-dense treatment for triple-negative breast cancer

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Aktive Filter

Suchergebnisse filtern